CVS Health Stock Surges 4.8% Following Upgraded 2026 Profit Outlook

Key Facts

1CVS Health stock rose 4.80% to reach $89.13 during September 25, 2026 trading.

2The company reported $106.1 billion in revenue and $2.58 adjusted EPS for the second quarter.

3CVS Health raised its full-year 2026 outlook while focusing on debt reduction and future investments.

CVS Health stock rose 4.80% to reach $89.13 during September 25, 2026 trading. AD HOC NEWS reported that the company posted second-quarter revenue of $106.1 billion and adjusted earnings per share of $2.58, leading management to raise its full-year 2026 outlook.

CVS closed at $89.13 on September 25, 2026, with the stock trading between a day low of $84.7 and a high of $89.35. According to company disclosures, the full-year adjusted EPS guidance was upgraded to a range of $7.90 to $8.10, supported by a debt reduction strategy that saw leverage improve from 5 times debt-to-EBITDA in 2024 to the mid-3s by 2026.